The serum GNG5 levels in mild AD (average 289.9 ± 231.6 pg/mL) were significantly lower than those in moderate AD (average 524.0 ± 231.6, p < 0.05), with no significant differences between the other groups. Here, GNG5 is linked to Alzheimer disease.